# Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

> **NCT06976853** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Crohn Disease (CD)

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Standard of care treatment

## Key facts

- **NCT ID:** NCT06976853
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2028-05
- **Final completion:** 2028-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06976853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06976853, "Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06976853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*